Sleep Number’s first quarter saw a substantial shortfall versus Wall Street expectations, prompting a significant negative market response. Management attributed the revenue and earnings declines primarily to a weaker retail environment early in the quarter and disruption caused by the full product line reset. CEO Linda Findley highlighted that demand improved in March as new products were introduced and legacy inventory was cleared, but most of the sales benefit will not materialize until subsequent quarters. Leadership acknowledged the ongoing challenges, emphasizing that the transition period and cost structure remain key obstacles to near-term profitability.
Is now the time to buy SNBR? Find out in our full research report (it’s free for active Edge members).
Sleep Number (SNBR) Q1 CY2026 Highlights:
- Revenue: $319 million vs analyst estimates of $320.7 million (18.9% year-on-year decline, 0.5% miss)
- Adjusted EPS: -$0.94 vs analyst estimates of -$0.34 (significant miss)
- Adjusted EBITDA: $5.75 million vs analyst estimates of $11.35 million (1.8% margin, 49.3% miss)
- Operating Margin: -11.6%, down from 0.5% in the same quarter last year
- Locations: 577 at quarter end, down from 637 in the same quarter last year
- Same-Store Sales fell 3% year on year (-1% in the same quarter last year)
- Market Capitalization: $35.73 million
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Sleep Number’s Q1 Earnings Call
- Peter Keith (Piper Sandler) pressed management on the likelihood of positive demand growth in Q2 and how the combination of new products and media spend could drive recovery. CEO Linda Findley reiterated that while product and marketing execution is on track, demand trends remain volatile and the company will remain flexible.
- Peter Keith (Piper Sandler) also questioned the timeline for recapitalization following the new term loan. CFO Amy O’Keefe confirmed the company expects a new financial plan or recap to be in place by the loan’s June 30 maturity, and lenders are monitoring progress closely.
- Peter Keith (Piper Sandler) asked about input cost inflation and mitigation strategies. Findley stated that new products were priced with current cost data and anticipated inflation, while O’Keefe added that cost savings initiatives are ongoing to offset headwinds.
- Daniel Silverstein (UBS) inquired about liquidity management and the impact of Memorial Day sales on cash flow. O’Keefe described tight liquidity controls and collaboration with lenders, expecting collections to ramp up during the holiday period.
- Bradley Thomas (KeyBanc Capital Markets) sought detail on average revenue per unit trends and future expectations. O’Keefe reported ARU was up slightly year-over-year, with further improvements expected as the new product mix shifts toward higher-value offerings.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be watching (1) whether the new product lineup drives sustained improvement in demand and average selling prices, (2) progress on securing longer-term financing or strategic alternatives to stabilize the balance sheet, and (3) continued realization of cost savings and operational efficiencies. Ongoing monitoring of consumer sentiment and macroeconomic headwinds will also be crucial for assessing turnaround momentum.
Sleep Number currently trades at $1.55, down from $2.45 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).
Our Favorite Stocks Right Now
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
